Compare

RELX/£REL

1D1W1M3M6MYTD1Y5YMAX

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
Ticker
£REL
Sector
Business services
Primary listing
LSE
Employees
37,000

RELX Metrics

BasicAdvanced
£52B
24.17
£1.25
0.26
£0.69
2.28%

What the Analysts think about RELX

Analyst ratings (Buy, Hold, Sell) for RELX stock.
Analyst projections of the future price of RELX stock.

Bulls say / Bears say

RELX delivered 7% underlying revenue growth in the first nine months of 2026 and kept its full-year outlook for strong revenue, operating profit and earnings growth. That gives investors evidence of continued momentum despite the market’s AI concerns. (Business Wire)
Legal grew 10%, led by adoption of RELX’s AI-enabled research and analytics platform. This suggests the company is turning its trusted legal content into products customers are willing to buy. (Business Wire)
Risk grew 8% and Scientific, Technical & Medical grew 6%, with demand for fraud and identity tools and uptake of new research products supporting performance. Growth across these businesses makes the investment case less reliant on Legal alone. (Business Wire)
AI competition could weaken RELX’s control of legal workflows or put pressure on pricing. Management acknowledged a fast-changing field that includes products from OpenAI, Google, Anthropic, Harvey and Legora, and said it must keep adapting its integrations and platform. (Stock Analysis)
Middle East disruption slowed Exhibitions: underlying growth was 4% in the first nine months, with the company attributing about three percentage points of impact to the disruption. Continued event disruption could hold back this segment’s contribution. (Stock Analysis)
RELX’s research business could face pressure if public funding cuts lead universities or researchers to rein in subscriptions. Interactive Investor also noted net debt had risen to 2.3 times adjusted EBITDA from 2.2 times, leaving less room for error if customer spending weakens. (interactive investor)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.

RELX Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

RELX Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.